Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Patent
1985-12-23
1987-06-23
Sneed, Helen M. S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
556 18, C07F 112, A01N 5502, A61K 3128
Patent
active
046754270
ABSTRACT:
Tetraphosphine-coordinated gold(I) compounds, pharmaceutical compositions containing an effective, tumor cell growth-inhibiting amount of such a compound, and a method for treating tumor cells sensitive to such a compound which comprises administering a tumor cell growth-inhibiting amount of such a compound to an animal afflicted by said tumor cells.
REFERENCES:
patent: 3676554 (1972-07-01), McGusty
patent: 3718680 (1973-02-01), McGusty
patent: 3842107 (1974-10-01), Sutton
patent: 3842108 (1974-10-01), Sutton
patent: 4097509 (1978-06-01), Schmidbaur et al.
patent: 4116990 (1978-09-01), Budnick
patent: 4186064 (1980-01-01), Morrissey
King et al., Inorg. Chem., vol. 10, No. 9, 1851-1860 (1971).
King et al., Inorg. Chem., vol. 10, No. 9, 1861-1867 (1971).
Berners-Price et al., Abstract #244, American Chemical Society (1986).
Mirabelli et al., Abstract #1114, Proceedings of AACR, 27, Mar. 1986.
Johnson et al., Abstract #1115, Proceedings of AACR 27, Mar. 1986.
Hill et al., Abstract #14, 190th American Chemical Society (1985).
Shaw et al., Inorganica Chimica Acta, 123, 213-216 (1986).
Eggleston et al., Inorganic Chimica Acta, 108, 221-226 (1985).
Mirabelli et al., Biochemical Pharmacology, 35(9), 1435-1443 (1986).
Mirabelli et al., Biochemical Pharmacology, 35(9), 1427-1433 (1986).
Mirabelli et al., J. Med. Chem., 29(2), 218-223 (1986).
Hill et al., Abstract #204, American Chemical Society (1986).
Cariati et al., Inorg. Chim. Acta, 1(2), 315-318 (1967).
McAuliffe, J. C. S. Dalton, 1730-1735 (1979).
Bates et al., Inorg. Chim. Acta, 81(2), 151-156 (1984).
Kuhn et al., Chemiker-Zeitung, 105(3), 87-88 (1981).
Berners-Price et al., J. Chem. Soc. Dalton Trans, 969-974 (1984).
Struck et al., J. Med. Chem., 9, 414-417 (1966).
Mirabelli et al., Proceedings of AACR Mar. 1984, No. 1455 p. 367 (1984).
Mirabelli et al., Cancer Research 45, 32-39 (1985).
Johnson et al., Proceedings of AACR Mar. 1985, No. 1001, p. 254 (1985).
Snyder et al., Proceedings of AACR Mar. 1985, No. 1007, p. 255 (1985).
Mirabelli et al., Proceedings of AACR Mar. 1985, No. 1008, p. 256 (1985).
Weinstock et al., J. Med. Chem., 17 (1), 139-140 (1974).
Hill David T.
Johnson Randall K.
Canter Carol G.
Lourie Alan D.
Smith Kline Beckman Corporation
Sneed Helen M. S.
Williams Janice E.
LandOfFree
Tetraphosphine-coordinated gold(I) complexes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetraphosphine-coordinated gold(I) complexes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetraphosphine-coordinated gold(I) complexes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-722474